Estrella Immunopharma Inc (ESLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,165 | 4,727 | 9,046 | 22,138 | 2,479 |
| Other current assets | 0 | 0 | 0 | 5,073 | 273 |
| TOTAL | $4,454 | $8,633 | $9,447 | $27,350 | $2,752 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 276 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $276 |
| Total Assets | $4,454 | $8,633 | $9,447 | $27,350 | $3,028 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 132 | 89 | 348 | 16,912 | 9,732 |
| Accrued Expenses | 4 | 4 | 6 | 24 | 22 |
| TOTAL | $181 | $139 | $399 | $17,281 | $9,758 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 13 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $13 |
| Total Liabilities | $181 | $139 | $399 | $17,281 | $9,771 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | 36,376 | 36,611 | 35,201 | 2,168 |
| Common Shares | 4 | 4 | 4 | 4 | 0 |
| Retained earnings | -19,500 | -15,549 | -15,080 | -14,059 | -12,189 |
| Other shareholders' equity | -354 | -84 | 0 | 0 | 0 |
| TOTAL | $4,274 | $8,495 | $9,049 | $10,069 | $-6,743 |
| Total Liabilities And Equity | $4,454 | $8,633 | $9,447 | $27,350 | $3,028 |